Abstract
Diagnosing and preventing Alzheimer’s disease is a complex task, partly due to being characterized by a lengthy asymptomatic stage. In order to tackle this, most preclinical studies are multidimensional in nature and largely focus on prevention through lifestyle interventions, such as improving nutrition and introducing physical as well as cognitive exercise. With the widespread use of mobile smart devices today, mobile health applications can help inform high-risk individuals at a low cost, while also aiding in the prevention of cognitive decline through constant virtual coaching services that contribute to lifestyle interventions. Under this light, a mobile application is developed in the context of this paper that provides risk assessment of individuals, daily monitoring of factors that have been found to help prevent cognitive impairment, and individually tailored guidance based on the individual’s progress. The developed application is also capable of reassessing users’ risk to track their progress, while also providing these services in an intuitive and user-friendly manner, which could enable the future development of more accurate models through the collected data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cataldo JK, Prochaska JJ, Glantz SA (2010) Cigarette smoking is a risk factor for Alzheimer’s disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 19(2):465–480
Crous-Bou M, Minguillon C, Gramunt N, Molinuevo JL (2017) Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9(1):71
Feng L, Li J, Yu JT, Zhang C, Yang B, Vellas B, Li C (2018) Prevention of Alzheimer’s disease in Chinese populations: status, challenges and directions
Flaten TP (2001) Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull 55(2):187–196
Fleminger S, Oliver D, Lovestone S, Rabe-Hesketh S, Giora A (2003) Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 74(7):857–862
Imtiaz B, Tolppanen AM, Kivipelto M, Soininen H (2014) Future directions in Alzheimer’s disease from risk factors to prevention. Biochem Pharmacol 88(4):661–670
Isaacson RS, Ganzer CA, Hristov H, Hackett K, Caesar E, Cohen R, Kachko R, Melendez-Cabrero J, Rahman A, Scheyer O et al (2018) The clinical practice of risk reduction for Alzheimer’s disease: a precision medicine approach. Alzheimers Dement 14(12):1663–1673
Khalsa DS (2015) Stress, meditation, and Alzheimer’s disease prevention: where the evidence stands. J Alzheimers Dis 48(1):1–12
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5(9):735–741. https://doi.org/10.1016/S1474-4422(06)70537-3. http://www.sciencedirect.com/science/article/pii/S1474442206705373
Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T et al (2013) The Finnish geriatric intervention study to prevent cognitive impairment and disability (finger): study design and progress. Alzheimers Dement 9(6):657–665
Langa KM (2015) Is the risk of Alzheimer’s disease and dementia declining? Alzheimers Res Ther 7(1):1–4
Lehtisalo J, Levalahti E, Lindstrom J, Hanninen T, Paajanen T, Peltonen M, Antikainen R, Laatikainen T, Strandberg T, Soininen H et al (2019) Dietary changes and cognition over 2 years within a multidomain intervention trial|the Finnish geriatric intervention study to prevent cognitive impairment and disability (finger). Alzheimers Dement 15(3):410–417
Lista S, Dubois B, Hampel H (2015) Paths to Alzheimer’s disease prevention: from modifiable risk factors to biomarker enrichment strategies. J Nutr Health Aging 19(2):154–163
Stergaard SD, Mukherjee S, Sharp SJ, Proitsi P, Lotta LA, Day F, Perry JR, Boehme KL, Walter S, Kauwe JS et al (2015) Associations between potentially modi able risk factors and alzheimer disease: a mendelian randomization study. PLoS Med 12(6):e1001841
Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, Sue LI, Beach TG (2003) Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer’s disease. Arterioscler Thromb Vasc Biol 23(11):2055–2062
Rosenberg A, Ngandu T, Rusanen M, Antikainen R, Backman L, Havulinna S, Hanninen T, Laatikainen T, Lehtisalo J, Levalahti E et al (2018) Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the finger trial. Alzheimers Dement 14(3):263–270
Rosenberg A, Mangialasche F, Ngandu T, Solomon A, Kivipelto M (2020) Multidomain interventions to prevent cognitive impairment, Alzheimer’s disease, and dementia: from finger to world-wide fingers. J Prev Alzheimers Dis 7(1):29–36
Sindi S, Mangialasche F, Kivipelto M (2015) Advances in the prevention of Alzheimer’s disease. F1000Prime Rep 7:50
Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA (2009) Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later. Dement Geriatr Cogn Disord 28(1):75–80
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Angelis, I. et al. (2021). Mobile Application for Monitoring and Preventing Cognitive Decline Through Lifestyle Intervention. In: Vlamos, P. (eds) GeNeDis 2020. Advances in Experimental Medicine and Biology, vol 1338. Springer, Cham. https://doi.org/10.1007/978-3-030-78775-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-78775-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78774-5
Online ISBN: 978-3-030-78775-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)